Published in Eur J Biochem on October 18, 1973
A single point mutation leads to an instability of the hetero-octameric structure of yeast phosphofructokinase. Biochem J (1999) 0.81
Differences in the degradation of yeast phosphofructokinase by proteinases A and B from yeast. Biochem J (1976) 0.75
[Column-chromatographic fractionation of rye grass pollen (Secale cereale)]. Arch Otorhinolaryngol (1978) 0.75
Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science (1998) 5.62
Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study. Lancet (1999) 3.20
Affinity chromatography of phosphofructokinase using Cibacron blue F3G-A. J Chromatogr (1972) 2.87
An improved procedure for protein staining in polyacrylamide gels with a new type of Coomassie Brilliant Blue. Anal Biochem (1972) 2.54
Arachnoid cysts associated with subdural hematomas and hygromas: analysis of 16 cases, long-term follow-up, and review of the literature. Neurosurgery (1997) 1.96
A conserved structural motif for lipopolysaccharide recognition by procaryotic and eucaryotic proteins. Structure (2000) 1.85
Is there a benefit of preoperative meningioma embolization? Neurosurgery (2000) 1.75
Förster excitation energy transfer in peridinin-chlorophyll-a-protein. Biophys J (2000) 1.62
Differentiation between intracerebral hemorrhage and ischemic stroke by transcranial color-coded duplex-sonography. Stroke (1998) 1.45
The ABC maltose transporter. Mol Microbiol (1998) 1.44
[Reciprocity of yeast-phosphofructokinase with dextran blue 2000]. Eur J Biochem (1971) 1.31
Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology (1999) 1.27
Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol (2000) 1.27
Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther (2008) 1.26
Peridinin chlorophyll a protein: relating structure and steady-state spectroscopy. Biochemistry (2000) 1.24
Polygraphic studies of normal infants during the first six months of life: III. Incidence of apnea and periodic breathing. Pediatrics (1977) 1.23
Do arachnoid cysts grow? A retrospective CT volumetric study. Neuroradiology (1991) 1.16
Solid-cystic (papillary-cystic) tumours within and outside the pancreas in men: report of two patients. Virchows Arch A Pathol Anat Histopathol (1991) 1.10
The significance of phosphofructokinase to the regulation of carbohydrate metabolism. Rev Physiol Biochem Pharmacol (1976) 1.06
Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry (1997) 1.05
Cerebral activation patterns in patients with writer's cramp: a functional magnetic resonance imaging study. J Neurol (2001) 1.05
The first three-dimensional structure of phosphofructokinase from Saccharomyces cerevisiae determined by electron microscopy of single particles. J Struct Biol (2001) 1.03
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol (2004) 1.01
Characterization of transmembrane domains 6, 7, and 8 of MalF by mutational analysis. J Bacteriol (1996) 1.00
"De novo" formation of intracranial aneurysms: who is at risk? Neuroradiology (1999) 0.98
Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging. J Neurol (1999) 0.98
Interobserver agreement in assessing early CT signs of middle cerebral artery infarction. AJNR Am J Neuroradiol (1996) 0.97
Intravascular MR tracking catheter: preliminary experimental evaluation. AJR Am J Roentgenol (1995) 0.96
Three-year follow-up of a patient with early-onset Alzheimer's disease with presenilin-2 N141I mutation - case report and review of the literature. Eur J Med Res (2008) 0.95
Transcranial color-coded real-time sonography in the evaluation of intracranial neoplasms and arteriovenous malformations. Neurosurgery (1992) 0.95
MR-guided percutaneous angioplasty: assessment of tracking safety, catheter handling and functionality. Cardiovasc Intervent Radiol (1999) 0.94
[On regulation of the multiphasic course of aerobic and anaerobic glucose utilization in yeast cells]. Acta Biol Med Ger (1967) 0.93
Phosphofructokinase from yeast. Methods Enzymol (1982) 0.93
Epitope mapping by screening of phage display libraries of a monoclonal antibody directed against the receptor binding domain of human alpha2-macroglobulin. FEBS Lett (1997) 0.93
The basal ganglia in haemochromatosis. Neuroradiology (2000) 0.93
Diminished insulin response in highly trained athletes. Metabolism (1978) 0.92
Technical failure rates of double crown-retained removable partial dentures. Clin Oral Investig (2000) 0.92
[Management of occult malformations at the lateral skull base]. Laryngorhinootologie (2005) 0.91
Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis (1992) 0.91
Physicochemical parameters and subunit composition of yeast phosphofructokinase. Eur J Biochem (1977) 0.89
[Determination of biological activity in soil with enzyme methods]. Adv Enzymol Relat Areas Mol Biol (1966) 0.89
[Acute organic psychosis after malaria tropica]. Nervenarzt (1996) 0.89
Limited proteolysis of yeast phosphofructokinase by subtilisin. Alterations in enzyme activity, subunit composition, and hydrodynamic properties. Eur J Biochem (1975) 0.89
Cerebral activation pattern in primary writing tremor. J Neurol Neurosurg Psychiatry (2000) 0.89
[On the multiple forms of yeast hexokinase]. Eur J Biochem (1969) 0.88
Similarity of activation of yeast phosphofructokinase by AMP and fructose-2,6-bisphosphate. Biochem Biophys Res Commun (1983) 0.87
Affinity partitioning of phosphofructokinase from baker's yeast using polymer-bound Cibacron blue F3G-A. Eur J Biochem (1983) 0.87
An evolutionarily conserved tripartite tryptophan motif stabilizes the prodomains of cathepsin L-like cysteine proteases. Eur J Biochem (2000) 0.87
The "dense artery sign"--major cerebral artery thromboembolism demonstrated by computed tomography. Neuroradiology (1990) 0.86
[Possible errors in the determination of metabolite concentrations in yeast cells]. Experientia (1967) 0.86
Kinetic modelling of yeast phosphofructokinase. Acta Biol Med Ger (1979) 0.85
MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy. J Neurol (1989) 0.85
Monitoring fluorescence of individual chromophores in peridinin-chlorophyll-protein complex using single molecule spectroscopy. Biochim Biophys Acta (2007) 0.85
Biochemical and clinical observations in four patients with fructose-1,6-diphosphatase deficiency. Eur J Pediatr (1990) 0.85
Developmental changes of glycogen phosphorylase b isozymes in rat tissues. Biomed Biochim Acta (1983) 0.85
Guidewire antennas for MR fluoroscopy. Magn Reson Med (1997) 0.85
Focal myositis of the temporal muscle. Muscle Nerve (1993) 0.85
Vascular interventions guided by ultrafast MR imaging: evaluation of different materials. Magn Reson Med (1994) 0.84
Characterization of transmembrane segments 3, 4, and 5 of MalF by mutational analysis. J Bacteriol (2001) 0.84
[Improvement of temperature and vibration sense in chronic uremia after a single dialysis]. Fortschr Neurol Psychiatr (1995) 0.84
The 15-kDa forms of the apo-peridinin-chlorophyll a protein (PCP) in dinoflagellates show high identity with the apo-32 kDa PCP forms, and have similar N-terminal leaders and gene arrangements. Mol Genet Genomics (2001) 0.84
Biochemistry of liver development in the perinatal period. Experientia (1983) 0.84
Inhibition of rat liver phosphofructokinase-2 by phosphoenolpyruvate and ADP. Biochem Biophys Res Commun (1984) 0.84
Peridinin-chlorophyll-protein reconstituted with chlorophyll mixtures: preparation, bulk and single molecule spectroscopy. FEBS Lett (2006) 0.84
Cerebellar arachnoid cyst in a firesetter: the weight of organic lesions in arson. J Psychiatry Neurosci (1996) 0.84
Comparison of transcranial sonography, magnetic resonance imaging, and single photon emission computed tomography findings in idiopathic spasmodic torticollis. Mov Disord (1997) 0.83
Isolated meningeal tuberculoma mimicking meningioma: case report. Surg Neurol (1995) 0.83
Uncommon morphologic characteristics in Leigh's disease. AJNR Am J Neuroradiol (1999) 0.83
In vitro demonstration of alternate stationary states in an open enzyme system containing phosphofructokinase. Arch Biochem Biophys (1980) 0.83
MR imaging-guided intravascular procedures: initial demonstration in a pig model. Radiology (1997) 0.82
Some kinetic and molecular properties of yeast phosphofructokinase. FEBS Lett (1968) 0.82
Visualization of vascular guidewires using MR tracking. J Magn Reson Imaging (1998) 0.82
Familial glomerulopathy with giant fibrillar deposits. Virchows Arch A Pathol Anat Histol (1980) 0.82
Effects of trypsin on yeast phosphofructokinase. Acta Biol Med Ger (1974) 0.82
Studies on the association behaviour of human-erythrocyte phosphofructokinase. Eur J Biochem (1973) 0.82
Evidence for phosphorylation of yeast phosphofructokinase. FEBS Lett (1988) 0.82
Postoperative neuroimaging of high-grade gliomas: comparison of transcranial sonography, magnetic resonance imaging, and computed tomography. Neurosurgery (1999) 0.82
Self-association of human erythrocyte phosphofructokinase. Kinetic behaviour in dependence on enzyme concentration and mode of association. Eur J Biochem (1976) 0.81
[Hexokinase as limiting factor of anaerobic glucose consumption of Saccharomyces carlsbergensis NCYC74]. Biochim Biophys Acta (1965) 0.81
MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects. Psychiatry Res (1997) 0.81
Small-angle x-ray scattering studies on the quaternary structure of phosphofructokinase from baker's yeast. FEBS Lett (1978) 0.81
Fructose-2,6-bisphosphate increases the binding affinity of yeast phosphofructokinase to AMP. Biochem Biophys Res Commun (1982) 0.81